F/m Emerald Life Sciences Innovation ETF is a registered fund series of RBB Fund, Inc. (series S000088167). Net assets $105.1M as of 2026-05-31.
Showing 15 of 40 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Travere Therapeutics Inc | TVTX | $8.1M | 766.63% |
| Cogent Biosciences Inc | COGT | $7.9M | 752.51% |
| LivaNova PLC | LIVN | $7.5M | 710.97% |
| Spyre Therapeutics Inc | SYRE | $6.7M | 640.75% |
| Guardant Health Inc | GH | $5.8M | 551.72% |
| Mirum Pharmaceuticals Inc | MIRM | $5.2M | 491.86% |
| Corcept Therapeutics Inc | CORT | $5.0M | 479.23% |
| United Therapeutics Corp | UTHR | $4.4M | 415.57% |
| VeraDermics Inc | MANE | $3.6M | 341.63% |
| Savara Inc | SVRA | $3.4M | 322.23% |
| Cytokinetics Inc | CYTK | $3.3M | 316.13% |
| Nektar Therapeutics | NKTR | $3.3M | 314.18% |
| Trevi Therapeutics Inc | TRVI | $3.3M | 311.71% |
| Dianthus Therapeutics Inc | DNTH | $3.2M | 308.83% |
| Axsome Therapeutics Inc | AXSM | $3.0M | 283.96% |
| Report date | Net assets |
|---|---|
| 2026-05-31 | $105.1M |
| 2026-02-28 | $95.7M |
| 2025-11-30 | $93.1M |
| 2025-08-31 | $64.6M |
| 2025-05-31 | $51.2M |
| 2025-02-28 | $52.5M |
| 2024-11-30 | $54.6M |